Espirito Santo, V., Passos, J., Nzwalo, H., Carvalho, I., Santos, F., Martins, C., . . . Nunes, S. (2021). Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: A single-institution experience.
Chicago Style (17th ed.) CitationEspirito Santo, Vera, et al. Selumetinib for Plexiform Neurofibromas in Neurofibromatosis Type 1: A Single-institution Experience. 2021.
MLA (8th ed.) CitationEspirito Santo, Vera, et al. Selumetinib for Plexiform Neurofibromas in Neurofibromatosis Type 1: A Single-institution Experience. 2021.
Warning: These citations may not always be 100% accurate.